Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007

Cancer Epidemiology

Volumn 36, Issue 4, 2012, Pages

  Coupland, Victoria H ^a   Kocher, Hemant M ^b   Berry, David P ^c   Allum, William ^d   Linklater, Karen M ^a   Konfortion, Julie ^a   Møller, Henrik ^a   Davies, Elizabeth A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Biliary; Cancer; England; Gallbladder; Incidence; Liver; Pancreas; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CANCER; CANCER INCIDENCE; CANCER SURVIVAL; CONTROLLED STUDY; DUODENUM CANCER; FEMALE; GALLBLADDER CANCER; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; SEX DIFFERENCE; UNITED KINGDOM; VATER PAPILLA CARCINOMA;

AGED; AGED, 80 AND OVER; BILIARY TRACT NEOPLASMS; ENGLAND; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; SURVIVAL RATE;

EID: 84863425145     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.03.010     Document Type: Article

References (41)

1. Department of Health Guidance on commissioning cancer services: improving outcomes in upper gastro-intestinal cancers: the manual 2001, Department of Health, London.
2. Office for National Statistics Cancer statistics registrations: registrations of cancer diagnosed in England, 2007 2010, ONS, London, England: Series MB1 No. 38.
3. International Agency for Research on Cancer GLOBOCAN 2008 cancer factsheet: liver cancer incidence and mortality worldwide in 2008 2010, IARC, France.
4. Cancer Research UK Liver cancer - UK incidence statistics 2010.
5. National Cancer Intelligence Network Cancer incidence and mortality by cancer network, UK, 2005 2008, NCIN, UK, pp. 1-54.
6. National Cancer Intelligence Network One year cancer survival trends, England, 1985-2004 2008, NCIN, UK, pp. 1-52.
7. National Cancer Intelligence Network Cancer incidence by deprivation, England, 1995-2004 2008, NCIN, UK, pp. 1-32.
8. Department for Communities and Local Government The English indices of deprivation 2007: summary 2007, Communities and Local Government Publications, UK.
9. Hariharan D., Saied A., Kocher H.M. Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford) 2008, 10:58-62.
10. Karim-Kos H.E., de Vries E., Soerjomataram I., Lemmens V., Siesling S., Coebergh J.W.W. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008, 44:1345-1389.
11. Wood H.E., Gupta S., Kang J.Y., Quinn M.J., Maxwell J.D., Mudan S., et al. Pancreatic cancer in England and Wales 1975-2000: patterns and trends in incidence, survival and mortality. Aliment Pharm Therap 2006, 23:1205-1214.
12. Quinn M.J., Babb P.J., Brock A., Kirby L., Jones J. Cancer trends in England and Wales 1950-1999 2001, The Stationery Office, London.
13. van Boeckel P.G.A., Boshuizen H.C., Siersema P.D., Vrieling A., Kunst A.E., Ye W., et al. No association between educational level and pancreatic cancer incidence in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol 2010, 34:696-701.
14. Batty G.D., Kivimaki M., Morrison D., Huxley R., Smith G.D., Clarke R., et al. Risk factors for pancreatic cancer mortality: extended follow-up of the original Whitehall study. Cancer Epidemiol Biomarkers Prevent 2009, 18:673-675.
15. Smith G.D., Leon D., Shipley M.J., Rose G. Socioeconomic differentials in cancer among men. Int J Epidemiol 1991, 20:339-345.
16. Baastrup R., Sorensen M., Hansen J., Hansen R.D., Wurtzen H., Winther J.F. Social inequality and incidence of and survival from cancers of the oesophagus, stomach and pancreas in a population-based study in Denmark, 1994-2003. Eur J Cancer 2008, 44:1962-1977.
17. Brown J., Harding S., Bethune A., Rosato M. Longitudinal study of socio-economic differences in the incidence of stomach, colorectal and pancreatic cancers. Popul Trends 1998, 35-41.
18. Iodice S., Gandini S., Maisonneuve P., Lowenfels A.B. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 2008, 393:535-545.
19. Hruban R.H., Petersen G.M., Goggins M., Tersmette A.C., Offerhaus G.J., Falatko F., et al. Familial pancreatic cancer. Ann Oncol 1999, 10(Suppl. 4):69-73.
20. Ekbom A., Trichopoulos D. Pancreatic cancer. Textbook of cancer epidemiology 2008, 333-348. Oxford University Press, New York. H.O. Adami, D. Hunter, D. Trichopoulos (Eds.).
21. Berrington de Gonzalez A., Sweetland S., Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 2003, 89:519-523.
22. Hirani V., Zaninotto P., Primatesta P. Generalised and abdominal obesity and risk of diabetes, hypertension and hypertension-diabetes co-morbidity in England. Public Health Nutr 2008, 11:521-527.
23. Chari S.T., Leibson C.L., Rabe K.G., Timmons L.J., Ransom J., De Andrade M., et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 2008, 134:95-101.
24. Thomson C.S., Forman D. Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results?. Br J Cancer 2009, 101:S102-S109.
25. Mitry E., Rachet B., Quinn M.J., Cooper N., Coleman M.P. Survival from cancer of the pancreas in England and Wales up to 2001. Br J Cancer 2008, 99:S21-S23.
26. Albores-Saavedra J., Schwartz A.M., Batich K., Henson D.E. Cancers of the ampulla of Vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. J Surg Oncol 2009, 100:598-605.
27. Chow W.H., McLaughlin J.K., Menck H.R., Mack T.M. Risk-factors for extrahepatic bile-duct cancers - Los-Angeles-County, California (USA). Cancer Cause Control 1994, 5:267-272.
28. Henson D.E., Schwartz A.M., Nsouli H., Albores-Saavedra J. Carcinomas of the pancreas, gallbladder, extrahepatic bile ducts, and ampulla of Vater share a field for carcinogenesis: a population-based study. Arch Pathol Lab Med 2009, 133:67-71.
29. West J., Wood H., Logan R.F.A., Quinn M., Aithal G.P. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer 2006, 94:1751-1758.
30. Weiderpass E., Pukkala E. Time trends in socioeconomic differences in incidence rates of cancers of gastro-intestinal tract in Finland. BMC Gastroenterol 2006, 6.
31. Altekruse S.F., McGlynn K.A., Reichman M.E. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009, 27:1485-1491.
32. Faggiano F., Partanen T., Kogevinas M., Boffetta P Socioeconomic differences in cancer incidence and mortality. IARC Sci Publ 1997, 65-176.
33. London W.T., McGlynn K.A. Liver cancer. Cancer epidemiology and prevention 2006, 763-786. Oxford University Press, New York. D. Schottenfeld, J.F. Fraumeni (Eds.).
34. National Cancer Intelligence Network Cancer incidence and survival, by major ethnic group, England 2002-2006 2009, NCIN, UK, pp. 1-64.
35. Harris H., Ramsay M., Costella A., Irvine N., McCartney M., Goldberg D., et al. Hepatitis C in the UK 2009 report 2009, Health Protection Agency Centre for Infections, London.
36. Hahne S., Ramsay M., Balogun K., Edmunds W.J., Mortimer P. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy. J Clin Virol 2004, 29:211-220.
37. Uddin G., Shoeb D., Solaiman S., Marley R., Gore C., Ramsay M., et al. Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin. J Viral Hepatitis 2010, 17:327-335.
38. Nakeeb A., Comuzzie A.G., Martin L., Sonnenberg G.E., Swartz-Basile D., Kissebah A.H., et al. Gallstones - genetics versus environment. Ann Surg 2002, 235:842-849.
39. Randi G., Franceschi S., La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006, 118:1591-1602.
40. Gourgiotis S., Kocher H.M., Solaini L., Yarollahi A., Tsiambas E., Salemis N.S. Gallbladder cancer. Am J Surg 2008, 196:252-264.
41. Chow W.H., Linet M.S., McLaughlin J.K., Hsing A.W., Chien H.T.C., Blot W.J. Risk-factors for small-intestine cancer. Cancer Cause Control 1993, 4:163-169.